🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/12/2016 | 134,38 | 134,38 | 129,13 | 131,51 | -3,82% | 3,91% | 705.900 |
| 06/12/2016 | 130,13 | 136,78 | 129,42 | 136,73 | +5,69% | 5,66% | 588.900 |
| 05/12/2016 | 127,28 | 131,13 | 127,28 | 129,37 | +2,28% | 3,02% | 506.000 |
| 02/12/2016 | 127,16 | 128,33 | 125,69 | 126,49 | -0,37% | 2,08% | 411.900 |
| 01/12/2016 | 126,47 | 127,96 | 125,39 | 126,96 | +1,07% | 2,03% | 493.700 |
| 30/11/2016 | 127,70 | 128,13 | 125,06 | 125,61 | -0,76% | 2,40% | 630.700 |
| 29/11/2016 | 129,26 | 130,42 | 126,38 | 126,57 | -4,65% | 3,13% | 529.700 |
| 28/11/2016 | 134,62 | 135,26 | 132,18 | 132,74 | -1,35% | 2,29% | 471.100 |
| 25/11/2016 | 132,22 | 135,19 | 131,16 | 134,55 | +2,41% | 3,05% | 251.100 |
| 23/11/2016 | 127,00 | 131,50 | 125,47 | 131,39 | +1,77% | 4,75% | 377.200 |
| 22/11/2016 | 131,45 | 132,00 | 127,03 | 129,10 | -1,79% | 3,78% | 462.000 |
| 21/11/2016 | 131,41 | 131,85 | 130,10 | 131,45 | +0,39% | 1,33% | 345.900 |
| 18/11/2016 | 133,50 | 133,50 | 130,49 | 130,94 | -1,92% | 2,25% | 455.700 |
| 17/11/2016 | 133,05 | 133,99 | 132,16 | 133,51 | +0,38% | 1,38% | 441.300 |
| 16/11/2016 | 134,65 | 136,88 | 132,74 | 133,01 | -1,61% | 3,07% | 488.000 |
| 15/11/2016 | 133,00 | 135,71 | 131,25 | 135,19 | +0,63% | 3,35% | 496.000 |
| 14/11/2016 | 127,22 | 134,48 | 126,90 | 134,35 | +5,79% | 5,96% | 962.100 |
| 11/11/2016 | 128,67 | 128,82 | 123,76 | 127,00 | -1,74% | 3,93% | 772.000 |
| 10/11/2016 | 131,00 | 134,50 | 128,09 | 129,25 | -0,56% | 4,89% | 942.400 |
| 09/11/2016 | 125,59 | 130,33 | 124,84 | 129,98 | +7,16% | 4,37% | 1.104.300 |
| 08/11/2016 | 118,55 | 122,01 | 117,28 | 121,29 | +1,46% | 3,99% | 518.100 |
| 07/11/2016 | 116,51 | 119,87 | 115,05 | 119,55 | +4,74% | 4,14% | 492.100 |
| 04/11/2016 | 113,76 | 116,83 | 113,51 | 114,14 | +0,63% | 2,92% | 535.800 |
| 03/11/2016 | 119,21 | 119,81 | 113,25 | 113,42 | -4,64% | 5,50% | 679.500 |
| 02/11/2016 | 119,26 | 120,26 | 118,70 | 118,94 | -0,79% | 1,31% | 446.800 |
| 01/11/2016 | 119,08 | 120,86 | 118,10 | 119,89 | -0,15% | 2,32% | 547.300 |
| 31/10/2016 | 118,41 | 121,46 | 118,00 | 120,07 | +1,63% | 2,92% | 653.400 |
| 28/10/2016 | 117,97 | 119,18 | 115,13 | 118,14 | +1,55% | 3,43% | 688.500 |
| 27/10/2016 | 114,83 | 119,21 | 112,56 | 116,34 | +2,88% | 5,79% | 1.001.500 |
| 26/10/2016 | 112,15 | 114,09 | 111,19 | 113,08 | +0,81% | 2,59% | 881.000 |